Diabetes

The SGLT-2 inhibitor is the first in its class to be approved for the treatment of adults with NYHA class II, III, or IV heart failure with reduced (≤40%) ejection fraction.

For your diabetes patients at home or soon to be at home, use these tips from the ADA and AACE on creating an emergency plan.

Based on results from REWIND, dulaglutide is the first GLP-1 receptor agonist to be approved for both primary and secondary CV prevention in type 2 diabetes.

Which 5 diets are best for your diabetes patients out of the 35 ranked most popular by US News & World Report health experts?

The new 3-in-1 oral therapy may help reduce treatment burden for T2D patients who most often require multiple agents.

A US diabetes diagnosis is made every 21 seconds; 40% of millennials with T2DM can't pay for treatment. And there is more PCPs will want to know.

Treatment with liraglutide for 26 weeks had no impact on bone resorption in patients with T2D, say authors of a new study.

Dapagliflozin received FDA priority review for reducing risk of CV death in adults with heart failure with reduced ejection fraction.

Type 1 diabetes patients who used the new system increased by 2.6 hours/day the amount of time spent in target blood glucose level range. 

Oral semaglutide, the first oral GLP-1 receptor agonsist, was approved by the FDA on Sept 20, 2019, becoming the only noninjectable formulation in the class.

US adults with type 2 diabetes have acheived negligible change in blood glucose levels, blood pressure, LDL-C levels, and smoking status in the past 15 years, according to a new study.

Less than half of PCPs responding to a recent survey chose correct values for prediabetes screening tests and seemed unaware of other evidence-based recommendations for prediabetes.

US adults with diagnosed diabetes are no closer to treatment goals than they were in 2005, according to a new study.

Help keep patients with diabetes healthy this flu season with a few of these quick reminders on vaccination, medication, comorbidities, and more. 

About 25% of patients with diabetes report asking a physician for a cheaper drug. Skipping doses and pill splitting are tactics used to cut costs.

One US researcher notes that using A1c alone to classify diabetes may misdiagnose >33 million Americans. What are the other options and how well do they work? Read on.

The novel intranasal glucagon delivered with a portable, single-use device could simplify treatment of this dangerous side effect of antidiabetes medications.

ADA 2019 ICYMI: Safety and efficacy of oral semaglutide in patients with T2DM was demonstrated in results of 3 PIONEER program clinical trials.  Highlights, here.

ADA 2019--Linagliptin, the DPP-4 inhibitor, showed similar risk for first or recurrent CV events or hopspitalization vs placebo in T2DM patients with high cardiorenal risk in CARMELINA subanalysis.

ADA 2019-Dapagliflozin reduced CV death, hospitalization for HF, and progression of CKD among T2DM patients with a wide distribution of baselines CVD risk in DECLARE-TIMI 58.

A personal EKG monitor, an app that wirelessly connects to a smart thermometer, and 3 more FDA-cleared apps for primary care. 

Refresh your memory of 4 CGM systems that received FDA-approval in 2018. Each one offers innovative features to help enhance diabetes care.

Diabetes is a progressive disease and takes advantage of inaction. How would you manage our patient Mrs Davis?

Who is at risk for T2DM? How often should you screen? What are the cut offs for Dx? Revisit the basics in 5 minutes or less.

More than one-third of those in recovery from drug/alcohol use have chronic physical disease. A novel study looks at prevalence of health issues by type of substance used.

Find out what you know about which diabetes drugs in which classes show CV protective properties and results of the trials that support their use.

Findings: a heart-healthy lifestyle reduces DM risk; 1 egg a day may protect against T2DM; and a new genetic risk score may improve DM diagnosis.

Help your patients with diabetes help themselves. See 5 apps at-a-glance you can discuss at the next visit.

Sample: True or false? The prevalence of undiagnosed diabetes is higher among obese adults vs overweight adults.